Terazosin Hydrochloride
- Product NDC
- 50436-4247
- 11-digit product format
- 504364247
- Labeler code
- 50436
- Product ID
- 50436-4247_4c3698d1-517f-41ec-b617-8de8db8f5751
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA074823
- Marketing category
- ANDA
- Marketing start
- 1998-03-30
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record